MEISSA VACCINES
Meissa Vaccines is a start-up pharmaceutical development company focused on the in-licensing and advancement of vaccines for respiratory syncytial virus (RSV, the largest unmet respiratory medical need in pediatrics) and rhinovirus (leading cause of infectious disease worldwide). Their passion is child health, but our vaccine programs have the potential to benefit multiple age groups directly and indirectly. Successful vaccines for respiratory syncytial virus and rhinovirus would have widespread benefits for society and families. These include reducing the burden of acute lower respiratory tract disease, reducing colds, reducing acute asthma exacerbations caused by these viruses, and alleviating missed school and work.
MEISSA VACCINES
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.meissavaccines.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
33.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Organization Schema Office 365 Mail
Similar Organizations
Affinivax
Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
MBX Capital
MBX Capital investment in Series A - Meissa Vaccines
Morningside Venture Investments
Morningside Venture Investments investment in Series A - Meissa Vaccines
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-11 | Meissa Vaccines Appoints Frank Glavin Chief Executive Officer |
Official Site Inspections
http://www.meissavaccines.com Semrush global rank: 2.82 M Semrush visits lastest month: 5.75 K
Unable to get host informations!!!
